(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 1.81%32.67M | ---- | -66.81%32.09M | ---- | 125.64%96.68M | ---- | 522.40%42.85M | ---- | 100.71%6.88M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -21.15%-16.6M | ---- | -1,388.91%-13.7M | ---- | 4.47%-920K | ---- | -57.61%-963K | ---- | 93.00%-611K |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -135.71%-5K |
Impairment and provisions: | ---- | 140.83%2.89M | ---- | -76.11%1.2M | ---- | 166.24%5.02M | ---- | -189,425.00%-7.58M | ---- | -100.00%-4K |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | 105.77%52K | ---- | -22,425.00%-901K | ---- | ---4K |
-Impairment of trade receivables (reversal) | ---- | 140.83%2.89M | ---- | -75.86%1.2M | ---- | 108.97%4.97M | ---- | ---55.39M | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --48.71M | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | -72.32%-2.14M | ---- | 15.25%-1.24M | ---- | -196.69%-1.46M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | -72.32%-2.14M | ---- | 15.25%-1.24M | ---- | -196.69%-1.46M |
Asset sale loss (gain): | ---- | -1,850.00%-312K | ---- | 99.98%-16K | ---- | -7,211.58%-94.69M | ---- | 72.05%-1.3M | ---- | -1,597.07%-4.63M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---94.01M | ---- | ---- | ---- | ---4.03M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 56.25%-7K | ---- | 97.64%-16K | ---- | 31.48%-679K | ---- | -290.16%-991K | ---- | -104.73%-254K |
-Loss (gain) from selling other assets | ---- | ---305K | ---- | ---- | ---- | ---- | ---- | 13.14%-304K | ---- | 93.79%-350K |
Depreciation and amortization: | ---- | -0.02%18.91M | ---- | -21.71%18.91M | ---- | -21.03%24.15M | ---- | -12.29%30.58M | ---- | -5.61%34.87M |
-Depreciation | ---- | 1.15%18.74M | ---- | -22.85%18.53M | ---- | -20.75%24.01M | ---- | -11.08%30.3M | ---- | -2.00%34.08M |
-Amortization of intangible assets | ---- | -56.81%165K | ---- | 176.81%382K | ---- | -51.24%138K | ---- | -64.31%283K | ---- | -0.50%793K |
Financial expense | ---- | 9.57%30.34M | ---- | 1.02%27.69M | ---- | -23.78%27.41M | ---- | -15.45%35.96M | ---- | -13.51%42.54M |
Exchange Loss (gain) | ---- | -409.30%-438K | ---- | -171.67%-86K | ---- | -99.03%120K | ---- | 323.43%12.37M | ---- | -139.86%-5.54M |
Special items | ---- | -99.83%5K | ---- | -76.47%2.86M | ---- | 2,065.12%12.17M | ---- | 15.64%562K | ---- | 57.79%486K |
Operating profit before the change of operating capital | ---- | -2.15%67.47M | ---- | 1.69%68.95M | ---- | -39.05%67.81M | ---- | 53.38%111.25M | ---- | -0.56%72.53M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -179.68%-12.13M | ---- | 220.74%15.23M | ---- | -38.62%-12.61M | ---- | 61.35%-9.1M | ---- | -402.50%-23.54M |
Accounts receivable (increase)decrease | ---- | 119.25%9.2M | ---- | -143.96%-47.76M | ---- | 2,397.01%108.65M | ---- | -98.70%4.35M | ---- | 46.11%335.02M |
Accounts payable increase (decrease) | ---- | 3.32%166.44M | ---- | -23.92%161.09M | ---- | -17.89%211.73M | ---- | 107.48%257.85M | ---- | 216.62%124.27M |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 91.98%-29.73M | ---- | -1,694.37%-370.83M |
Cash from business operations | -115.73%-19.06M | 16.94%230.97M | 8.39%121.13M | -47.41%197.5M | -66.80%111.76M | 12.24%375.57M | 256.50%336.66M | 143.44%334.62M | 69.83%94.43M | -19.30%137.45M |
Other taxs | -19.85%-1.31M | -321.17%-2.53M | -653.79%-1.09M | 64.20%-600K | 74.25%-145K | -158.24%-1.68M | 47.28%-563K | 89.75%-649K | 82.38%-1.07M | 65.12%-6.33M |
Net cash from operations | -116.97%-20.37M | 16.02%228.44M | 7.55%120.04M | -47.34%196.9M | -66.79%111.61M | 11.95%373.89M | 259.97%336.09M | 154.70%333.97M | 88.44%93.37M | -13.83%131.12M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -17.85%5.5M | 21.15%16.6M | -50.24%6.7M | 1,388.91%13.7M | 1,606.34%13.46M | -4.47%920K | 62.35%789K | 57.61%963K | --486K | -93.00%611K |
Decrease in deposits (increase) | 145.27%66.75M | -133.81%-142.71M | -271.19%-147.45M | -83.20%-61.04M | -15.33%-39.72M | -4.35%-33.32M | 5.93%-34.44M | 73.27%-31.93M | 65.66%-36.61M | -139.39%-119.45M |
Sale of fixed assets | -89.66%3K | -9.38%29K | -14.71%29K | -98.82%32K | -98.48%34K | 30.30%2.72M | 1,560.74%2.24M | 111.01%2.09M | -90.88%135K | 81.32%990K |
Purchase of fixed assets | 60.01%-1.02M | -3.53%-3.75M | -394.75%-2.54M | 4.55%-3.63M | 84.34%-514K | -102.94%-3.8M | 1.05%-3.28M | 44.52%-1.87M | -38.65%-3.32M | 51.29%-3.37M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---137K | ---137K | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | -140.65%-1.33M | ---1.33M | -86.08%3.26M | ---- | --23.43M |
Recovery of cash from investments | --13.52M | --5.02M | ---- | ---- | ---- | ---- | ---- | -93.12%928K | ---- | --13.49M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 29.06%-2.02M |
Net cash from investment operations | 159.16%84.75M | -145.08%-124.83M | -435.76%-143.26M | -45.79%-50.93M | 26.05%-26.74M | -31.55%-34.94M | 8.02%-36.16M | 69.23%-26.56M | 63.37%-39.31M | -128.52%-86.32M |
Net cash before financing | 377.20%64.38M | -29.02%103.61M | -127.37%-23.23M | -56.94%145.97M | -71.70%84.87M | 10.26%338.96M | 454.87%299.94M | 586.12%307.41M | 193.56%54.06M | -90.15%44.8M |
Cash flow from financing activities | ||||||||||
New borrowing | -38.41%90.49M | -16.67%385.79M | -18.77%146.91M | -39.93%462.97M | -41.35%180.86M | -3.91%770.73M | -31.97%308.34M | -5.66%802.09M | -14.55%453.23M | -38.52%850.25M |
Refund | -9.36%-145.27M | 21.96%-467.64M | 53.95%-132.84M | 42.43%-599.27M | 52.10%-288.47M | 5.44%-1.04B | -10.94%-602.28M | -40.36%-1.1B | -44.80%-542.88M | 56.28%-784.28M |
Interest paid - financing | 29.05%-11.95M | -9.57%-30.34M | -9.76%-16.84M | -7.51%-27.69M | -4.56%-15.35M | 20.83%-25.76M | 10.97%-14.68M | 11.02%-32.53M | 8.36%-16.49M | 25.65%-36.57M |
Net cash from financing operations | -2,308.19%-66.73M | 31.58%-112.2M | 97.75%-2.77M | 45.50%-163.99M | 60.77%-122.96M | 10.54%-300.9M | -188.96%-313.44M | -2,449.40%-336.36M | -182.12%-108.47M | 103.11%14.32M |
Effect of rate | -162.42%-103K | 47.44%115K | 2,850.00%165K | 141.94%78K | 93.02%-6K | -204.92%-186K | 25.86%-86K | -354.17%-61K | 48.67%-116K | 114.72%24K |
Net Cash | 90.96%-2.35M | 52.34%-8.59M | 31.75%-26M | -147.35%-18.02M | -182.16%-38.09M | 231.44%38.06M | 75.19%-13.5M | -148.97%-28.95M | -173.23%-54.42M | 1,126.76%59.12M |
Begining period cash | -14.17%51.32M | -23.08%59.79M | -23.08%59.79M | 94.99%77.74M | 94.99%77.74M | -42.12%39.87M | -42.12%39.87M | 607.61%68.88M | 607.61%68.88M | -37.82%9.73M |
Cash at the end | 43.90%48.87M | -14.17%51.32M | -14.32%33.96M | -23.08%59.79M | 50.83%39.64M | 94.99%77.74M | 83.19%26.28M | -42.12%39.87M | -82.88%14.35M | 607.61%68.88M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | -- |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data